281 related articles for article (PubMed ID: 22684349)
21. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
[TBL] [Abstract][Full Text] [Related]
22. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
23. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis.
Erkan O; Bozdayi AM; Disibeyaz S; Oguz D; Ozcan M; Bahar K; Karayalcin S; Ozden A; Bozkaya H; Yurdaydin C; Uzunalimoglu O
Eur J Gastroenterol Hepatol; 2005 Mar; 17(3):339-43. PubMed ID: 15716659
[TBL] [Abstract][Full Text] [Related]
24. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
[TBL] [Abstract][Full Text] [Related]
25. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.
Kenet G; Sadetzki S; Murad H; Martinowitz U; Rosenberg N; Gitel S; Rechavi G; Inbal A
Stroke; 2000 Jun; 31(6):1283-8. PubMed ID: 10835445
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
[TBL] [Abstract][Full Text] [Related]
27. Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.
Lenicek Krleza J; Jakovljevic G; Bronic A; Coen Herak D; Bonevski A; Stepan-Giljevic J; Roic G
Pathophysiol Haemost Thromb; 2010; 37(1):24-9. PubMed ID: 20664190
[TBL] [Abstract][Full Text] [Related]
28. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
[TBL] [Abstract][Full Text] [Related]
29. Inherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutation.
Torun YA; Patiroglu T; Ozdemir MA; Ozkul Y; Ekici A; Karakukcu M
Clin Appl Thromb Hemost; 2012; 18(2):218-21. PubMed ID: 21873357
[TBL] [Abstract][Full Text] [Related]
30. Thrombophilia in infancy: factor V Leiden and MTHFR or factor II double heterozygocity as a risk factor.
Koren A; Levin C; Hujirat Y; El-Hasid R; Kutai M; Lanir N; Shalev S; Brenner B
Pediatr Hematol Oncol; 2003; 20(3):219-27. PubMed ID: 12637218
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of thrombotic children with malignancy.
Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A
Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
[TBL] [Abstract][Full Text] [Related]
32. Thrombophilia testing in patients with portal vein thrombosis.
Kirkeby MH; Larsen JB; Grønbaek H; Hvas AM
Scand J Clin Lab Invest; 2020 Dec; 80(8):694-698. PubMed ID: 33026843
[TBL] [Abstract][Full Text] [Related]
33. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India.
Mohanty D; Shetty S; Ghosh K; Pawar A; Abraham P
Hepatology; 2001 Oct; 34(4 Pt 1):666-70. PubMed ID: 11584361
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
DeSancho MT; Berlus N; Christos PJ; Rand J
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
[TBL] [Abstract][Full Text] [Related]
35. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
Kabukcu S; Keskin N; Keskin A; Atalay E
Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
[TBL] [Abstract][Full Text] [Related]
36. Heterozygous prothrombin 20210G/A mutation, associated with hyperhomocysteinemia, and homozygous methylenetetrahydrofolate reductase 677C/T mutation, in a patient with portal and mesenteric venous thrombosis.
Elhajj II; Salem ZM; Birjawi GA; Taher AT; Soweid AM
Hematol J; 2004; 5(6):540-2. PubMed ID: 15570301
[TBL] [Abstract][Full Text] [Related]
37. Frequency of selected thrombophilias in women with placental abruption.
Procházka M; Lubuský M; Slavík L; Hrachovec P; Zielina P; Kudela M; Lindqvist PG
Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):297-301. PubMed ID: 17627684
[TBL] [Abstract][Full Text] [Related]
38. Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy.
Ogunyemi D; Cuellar F; Ku W; Arkel Y
Am J Perinatol; 2003 Jan; 20(1):17-24. PubMed ID: 12638077
[TBL] [Abstract][Full Text] [Related]
39. [Update thrombophilia].
Lindhoff-Last E; Luxembourg B; Pabinger I
Hamostaseologie; 2008 Dec; 28(5):365-75. PubMed ID: 19132167
[TBL] [Abstract][Full Text] [Related]
40. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
